Target Name: LOC105377095
NCBI ID: G105377095
Review Report on LOC105377095 Target / Biomarker Content of Review Report on LOC105377095 Target / Biomarker
LOC105377095
Other Name(s): Uncharacterized LOC105377095, transcript variant X2 | uncharacterized LOC105377095 | LOC105377095 variant X2

LOC105377095: A Promising Protein for Drug Targets and Biomarkers

LOC105377095 (Uncharacterized LOC105377095, transcript variant X2) is a protein that has been identified as a potential drug target and biomarker. The protein is derived from the human proteasome, which is a complex of proteinases and other cellular organelles that break down and recycle protein waste in the cell.

The proteasome is a key regulator of protein diversity and homeostasis in the cell. It is responsible for breaking down foreign proteins that are no longer needed and for ensuring that all proteins in the cell are functional and properlyfolded. The proteasome also plays a key role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

LOC105377095 is a unique protein that has been identified by researchers as having potential drug target and biomarker properties. It is characterized by its high sequence homology with the proteasome and its conserved catalytic residues, which are important features for protein-protein interactions and catalytic activity.

One of the key advantages of LOC105377095 as a potential drug target is its location on the cell surface. Unlike many other proteins that are involved in cellular signaling and signaling pathways, LOC105377095 is located in the cytosol, which is the fluid inside the cell. This location makes it more accessible to drugs and other therapeutic agents that can interact with it.

Another potential advantage of LOC105377095 is its role in the regulation of cellular processes. The proteasome is involved in the regulation of many cellular processes, including cell growth, apoptosis, and inflammation. By targeting LOC105377095, researchers may be able to gain insights into how this protein contributes to these processes and how it could be used to treat diseases.

In addition to its potential drug target and biomarker properties, LOC105377095 is also of interest due to its unique structure and function. The protein is characterized by a distinct N-terminus and a unique C-terminus that is involved in its catalytic activity. The N-terminus is known as the \" catalytic domain\" and is responsible for the protein's catalytic activity, while the C-terminus is known as the \"structural domain\" and is involved in the protein's stability and interactions with other proteins.

Research into LOC105377095 is still in its early stages, but it has the potential to lead to new treatments for a variety of diseases. As more research is conducted, researchers may be able to better understand its role in the regulation of cellular processes and its potential as a drug target.

In conclusion, LOC105377095 is a unique and promising protein that has the potential to be a drug target and biomarker. Its conserved catalytic residues and location on the cell surface make it a promising target for drugs that can interact with it. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: Uncharacterized LOC105377095

The "LOC105377095 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377095 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732 | LOC105377739 | LOC105377778 | LOC105377785 | LOC105377795 | LOC105377806 | LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010